Unlocking the Healthcare Market Implications of GLP-1 Drugs

from 4sight Health Roundup (for Healthcare Executives) · host 4sight Health Roundup

GLP-1 drugs are dominating the healthcare headlines from Medicare's new GLP-1 Bridge demonstration project to the explosion in the number of people using them for more than just weight loss. David W. Johnson and Julie Murchinson explore the market, policy and population health implications on, “Unlocking the Healthcare Market Implications of GLP-1 Drugs,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.

Episode metadata supplied by the publisher feed · Published Jul 16, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Unlocking the Healthcare Market Implications of GLP-1 Drugs

0:00 22:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 4sight Health Roundup (for Healthcare Executives)?

This episode is 22 minutes long.

When was this 4sight Health Roundup (for Healthcare Executives) episode published?

This episode was published on July 16, 2026.

Can I download this 4sight Health Roundup (for Healthcare Executives) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!